【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 12
1.2 List of Figures 23
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
3 Industry Overview 30
3.1 Emergence of Companion Diagnostics 30
3.1.1 Definition of Companion Diagnostics 30
3.1.2 Changing Face of Medicine 31
3.1.3 Definitions of Companion and Personalized Diagnostics 33
3.2 Disease Applications 35
3.2.1 Breast Cancer 35
3.2.2 Colorectal Cancer 38
3.2.3 Melanoma 40
3.2.4 Non-Small Cell Lung Cancer 41
3.3 Companion Diagnostics Technologies 43
3.3.1 Immunochemical Techniques 43
3.3.2 Nucleic Acid Testing 45
3.3.3 Emerging Technologies 52
3.4 Companion Diagnostics Development 54
3.4.1 Economic Value of a Companion Diagnostic 54
3.4.2 When to Develop a Companion Diagnostic Test 55
3.4.3 Strategy 58
3.4.4 Selection of Partner 59
3.4.5 Biomarker Discovery 61
3.5 Clinical Outcomes 62
3.5.1 Role of Companion Diagnostics in Disease Treatment 62
3.5.2 Companion Diagnostic Test Applications 63
3.6 Testing Trends 64
3.6.1 US 64
3.6.2 France 75
3.6.3 Germany 85
3.6.4 Italy 92
3.6.5 Spain 100
3.6.6 UK 106
3.6.7 Japan 120
3.6.8 Brazil 129
3.6.9 China 135
3.6.10 India 143
3.7 Market Access 150
3.7.1 Overview 150
3.7.2 US 150
3.7.3 5EU 154
3.7.4 Japan 165
3.7.5 Brazil 167
3.7.6 China 169
3.7.7 India 172
3.8 Regulatory Issues and Recalls 173
3.8.1 Dako FDA Warning Letter 173
3.8.2 HercepTest Recall 174
3.8.3 Cobas KRAS Test Recall 174
3.8.4 Cobas BRF V600E Test Recall 174
3.8.5 Leica Bond HER2 IHC System 174
3.9 Reimbursement of Companion Diagnostic Tests 175
3.9.1 US 175
3.9.2 Europe 180
3.9.3 APAC 192
3.9.4 South America 197
3.10 M&A, Key Partnerships 199
3.10.1 Significant Mergers and Acquisitions 201
3.10.2 Recent Partnerships 201
3.11 Economic Impact 207
3.11.1 Cost Effectiveness of Companion Diagnostics 207
3.11.2 Cost Effectiveness of Companion Diagnostics: Healthcare Provider Perspective 208
3.12 Market Drivers 214
3.12.1 Driver: Increasing Healthcare Pressures 214
3.12.2 Driver: Adverse Economic Pressures 215
3.12.3 Driver: Availability of New Technologies 215
3.12.4 Driver: FDA Regulatory Changes 216
3.12.5 Driver: Need to Improve Drug Development Processes 216
3.12.6 Driver: Increasing Cancer Incidence 217
3.12.7 Driver: Accelerating Demand for Targeted Therapies 217
3.13 Market Barriers 219
3.13.1 Barrier: Reimbursement Difficulties 219
3.13.2 Barrier: Loss of Indication 219
3.13.3 Barrier: Emergence of Biosimilar Therapies 220
3.13.4 Barrier: Competition with Laboratory-Developed Tests 221
3.13.5 Barrier: Emergence of Next-Generation Gene Sequencing 222
3.13.6 Barrier: Lack of Laboratory Choice in Instrument Selection 223
3.13.7 Barrier: Lack of Patient Awareness about Companion Diagnostic Tests 224
3.13.8 Barrier: Physician Resistance to New Companion Diagnostic Tests 225
4 Competitive Assessment 227
4.1 Overview 227
4.2 Techniques in Use by Currently Marketed Products 227
4.2.1 Immunohistochemistry 227
4.2.2 Fluorescence In Situ Hybridization 227
4.2.3 Polymerase Chain Reaction 228
4.3 Competitive Analysis 228
4.3.1 Breast Cancer Companion Diagnostic Tests 228
4.3.2 Colorectal Cancer Companion Diagnostic Tests 257
4.3.3 Melanoma Companion Diagnostic Tests 267
4.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 273
5 Unmet Needs 290
5.1 Need for Improved Cancer Treatments 290
5.2 Need for Objective Tests 290
5.3 Need for High-Throughput Tests 292
5.4 Certainty of Reimbursement 293
5.5 Amount and Type of Tissue Needed for Test 294
5.6 Who Should be Tested? 297
5.7 Test Accuracy 302
5.8 Increasing Test Complexity and Increased Process Failure 305
6 Pipeline Products 306
6.1 Overview 306
6.2 Pipeline by Phase of Development 308
6.3 Pipeline Product Profiles 310
6.3.1 Breast Cancer Companion Diagnostic Tests 310
6.3.2 Colorectal Cancer Companion Diagnostic Tests 318
6.3.3 Melanoma Companion Diagnostic Tests 324
6.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 331
7 Clinical Trials to Watch 347
7.1 Overview 347
7.2 Key Clinical Trials Utilizing Pipeline Companion Diagnostic Tests Linked to Specific Drug Therapies 351
8 Current and Future Players 352
8.1 Trends in Corporate Strategy 352
8.1.1 Companion Diagnostics Business Models 352
8.2 Company Profiles 353
8.2.1 Pharmaceutical/Therapy Companies Developing Companion Diagnostic Tests 353
8.2.2 Diagnostics Companies Developing Companion Diagnostic Tests (in Partnership with Pharmaceutical Companies) 409
9 Market Outlooks 492
9.1 By Market Segment 492
9.1.1 Breast Cancer Companion Diagnostic Tests 492
9.1.2 Colorectal Cancer Companion Diagnostic Tests 493
9.1.3 Melanoma Companion Diagnostic Tests 496
9.1.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 498
9.1.5 Technique 504
9.2 By Geography 507
9.2.1 10 Major Markets Overview 507
9.2.2 US 509
9.2.3 France 510
9.2.4 Germany 512
9.2.5 Italy 514
9.2.6 Spain 516
9.2.7 UK 518
9.2.8 Japan 520
9.2.9 Brazil 523
9.2.10 China 525
9.2.11 India 527
10 Appendix 530
10.1 Bibliography 530
10.2 Abbreviations 582
10.3 Report Methodology 584
10.3.1 Coverage 584
10.3.2 Secondary Research 585
10.3.3 Forecasting Methodology 585
10.4 Physicians Included in this Study 587
10.5 About the Authors 589
10.5.1 Andrew Thompson, Ph.D., Senior Analyst, In Vitro Diagnostics 589
10.5.2 Derek Archila, MBA, Lead Analyst, Medical Devices 589
10.5.3 Bonnie Bain, PhD, Global Head of Healthcare 590
10.6 Disclaimer 591
【レポート販売概要】
■ タイトル：腫瘍向けコンパニオン診断：グローバル市場分析と予測■ 英文：MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
■ 発行日：2014年5月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0189MAR
■ 調査対象地域：グローバル
- 自閉症障害：市場機会分析及び予測（～2018）OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018 Summary Autism Spectrum Disorders (ASD) is a chronically underserved market currently dominated by the two approved drugs, both of which are antipsychotics. There is off-label use of a multitude of other drugs which target different core and non-core symptoms of ASD. Since this disorder can first become appa …
- 水溶性ポッド包装の世界市場2019-2023106 pages, November 2018 About this market Since the introduction of P&G tide pods in 2012, the demand for single dose packaging has been increasing globally. The easy to use feature has made single dose packaging an instant hit among consumers. By using water soluble pods packaging, consumers can keep track of the amount of product consumed. Single dose consumer goods packaging is more popular in …
- 医療用食品の世界市場分析：製品タイプ別、用途タイプ別（糖尿病性ニューロパチー、[ADHD]、うつ病、アルツハイマー病、栄養欠乏）、セグメント予測、2014 – 2025The global medical foods market is expected to reach a value of USD 24.4 billion by 2025, according to a new report by Grand View Research, Inc. The medical foods market is anticipated to grow at a CAGR of 6.9% over the forecast period. The key factors supporting expansion include the growing awareness about medical foods, improvement in patient healthcare outcomes, rise in prevalence of several c …
- 低速車の北米市場“Increase in demand for green vehicles and changing face of transportation industry to drive the low speed vehicle market.”The low speed vehicle market in North America is projected to grow at a CAGR of 3.06%. From USD 3.57 billion in 2017 it is projected to reach USD 4.15 billion by 2022. The rising trend of using low speed vehicles in gated communities, resorts, industrial & college campuses is …
- Traverse Energy Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Traverse Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Traverse Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 4,4′-(9-Fluorenylidene)diphenolの世界市場4,4’-(9-Fluorenylidene)diphenol (CAS 3236-71-3) Market Research Report 2014 presents comprehensive data on 4,4’-(9-fluorenylidene)diphenol markets globally and regionally (Europe, Asia, North America etc.) The report includes 4,4’-(9-fluorenylidene)diphenol description, covers its application areas and related patterns. It overviews 4,4’-(9-fluorenylidene)diphenol market, names 4,4’-(9-fluorenylid …
- 燃料添加剤の世界市場2015-2019Technavio's market research analyst estimates the global fuel additives market to witness a steady growth at a rate of around 8% during the forecast period. The adoption of ethanol and biodiesel is expected to drive the market growth for fuel additives due to the usage of antioxidants, corrosion inhibitors, cold flow improvers, and other products. The rise in the adoption of hybrid electric vehicl …
- ハイバリア性パウチの世界市場2016-2020About Packaging Packaging has become an integral part in the supply chain of any industry. This increased the demand for packaging in different sectors such as food and beverages, agriculture, healthcare, and construction, which have introduced innovative packaging materials and designs. In the past two decades, the packaging industry has seen a huge transformation in terms of innovation. From sim …
- 世界のROADMコンポーネント市場動向（2012-2016）TechNavio's analysts forecast the Global ROADM Component market to grow at a CAGR of 29.22 percent over the period 2012-2016. One of the key factors contributing to this market growth increasing need to manage network traffic. The Global ROADM Component market has also been witnessing growing popularity of ROADM components in China. However, worsening economic conditions could pose a challenge to …
- 発電機販売の世界市場予測（～2021年）：ディーゼル発電機、ガス発電機The global generator sales market is projected to grow at a CAGR of 5.7% from 2016 to 2021, to reach a market size of USD 24.45 Billion in 2021. This growth is mainly attributed to increased demand for uninterrupted and reliable power supply from a wide range of end-users such as the residential, IT/telecom, healthcare, utility and power generation, oil & gas, mining, and construction sectors. The …
- 水溶性フィルムの世界市場：キシラン、PVA/PVOH水溶性フィルムWater soluble (PVA/PVOH) film is commercially made from polyvinyl alcohol resins and due to its water soluble property, is widely used for water soluble small dose packaging of detergents, agrochemicals, water treatment chemicals, dyes, and food. Apart from these applications, water soluble (PVA/PVOH) film is used in embroidery and laundry bag manufacturing. North America is the global leader of t …
- 前臨床用画像システムの世界市場：マイクロMRI、マイクロPET、マイクロCT、PAT、SPECT、マルチモダリティー、光学イメージング、超音波装置About Pre-clinical Imaging Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection o …
- 立体ディスプレイの世界市場：構成品（プロジェクター、モータ/ポジションセンサ）、技術（DLP、LCOS）、ディスプレイ種類、用途、地域別分析Volumetric displays generate a true 3D image by illuminating points in a 3D space. These displays typically have a 360° field of view, and a user does not have to wear shutter glasses or head-trackers to view an image; this is one of the advantages of volumetric displays over other 3D displays. Volumetric displays are incorporated with different components such as projectors, motor & position sens …
- 世界のComplex Event Processing (CEP)市場As current market scenario is increasingly competitive and highly complex, thereby demands to execute large business deals, operation level decisions and recognizing risk events ‘before hand’ is even more challenging. As well, it is essential to maintain a minimum amount of latency alongside to have sustainable business environment. Further, the circumstances are intensified by an ever-expanding s …
- 酪酸の世界市場2016-2020About Butyric Acid Butyric acid is a 4-carbon oxychemical. It is a carboxylic acid, which is oily and colorless, and occurs in many dairy products like milk, cheese, and butter. Butyric acid has esters and salts known as butanoates and butyrates. It exhibits an unpleasant smell and also has an acrid taste. It is used in stink bombs for its pungent smell. Some of its derivative chemicals and esters …
